Clinical Ink and Integron Partner to Streamline IoT-enabled Clinical Trials
Clinical Ink, provider of eSource and patient engagement technologies, and Integron, provider of managed services for the connected health and Internet of Things (IoT) industry, announced a partnership to extent Clinical Ink's capabilites in mobile device and sensor deployment, in order to engage and collect data from patients in clinical trials.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025